Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Clinical trials sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., explained in plain language.
-
New drug aims to help sepsis patients breathe on their own sooner
Disease control Recruiting nowThis study tests an experimental drug called YD0743 in adults with sepsis who develop severe lung failure (ARDS) and need a breathing machine. The goal is to see if the drug helps patients use the ventilator for fewer days and improves oxygen levels. About 309 ICU patients will r…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New pill aims to ease chronic sinus trouble without surgery
Disease control Recruiting nowThis study tests an experimental tablet called HTMC0658 in 30 adults with chronic sinusitis (sinus swelling lasting over 12 weeks) who do not have nasal polyps. The goal is to see if the drug improves sinus CT scans and reduces symptoms like congestion, facial pain, and nasal dis…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New pain pill could ease suffering after surgery
Symptom relief Recruiting nowThis study tests a new tablet called HL-1186 for moderate to severe pain after surgery. About 72 adults having orthopedic, abdominal, or chest surgery will receive either the drug or a placebo. The goal is to see if the drug reduces pain over 48 hours and to check for side effect…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New pill aims to ease pain after belly surgery
Symptom relief Recruiting nowThis study tests a new tablet called HL-1186 to see if it safely reduces moderate to severe pain after abdominal surgery. About 40 adults will receive either the drug or a placebo. The main goal is to measure pain relief over 48 hours using a standard pain scale.
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC